\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationAmsterdam, Netherlands
The EuroHPC Joint Undertaking and the EuroCC Netherlands organise the second EuroHPC User Day to bring together the EuroHPC Users community.
Attendees will be able to showcase EuroHPC projects that have used European HPC supercomputing resources, share best practices in the development of these projects, gather feedback from EuroHPC users and engage with potential new users.
Users of the EuroHPC JU systems are invited to present their work and the opportunity to submit papers setting the results of the projects that used EuropHPC resources. Papers need to show scientific excellence in the chosen thematic fields. The manuscripts can be submitted here before August 15, 2024. The papers should be a max of 10 pages and should contain an explanation of the experiment undertaken and what compute power of the supercomputer was used for.
For more information on the event, the conditions to submit papers and to register for the event please visit the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
